Cryoport, Inc.

Cryoport, Inc.CYRXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

Top Holders

Holder% OwnedSharesChangeAs of
NOS. OF ABOVE PERSONS10.43%
5.2M
-3.36pp2024-11-14
Cadian Capital Management, LP8.70%
4.3M
▲ +1.60pp2024-11-13
Integrated Core Strategies7.50%
3.7M
▲ +1.90pp2024-10-16
BlackRock, Inc.7.30%
3.6M
2024-01-26
The Vanguard Group5.74%
2.8M
flat2024-11-12
Alger Associates, Inc.5.50%
2.7M
▲ +1.40pp2024-11-14

Insider Transactions

Net 90d: $471.3K · buys $0 / sells $471.3K
Range:
Action:
Role:
InsiderRoleAction
2026-04-21SHELTON JERRELLPresident, CEOOption exercise
104.0K
$1.87$194.5K
2026-04-06SHELTON JERRELLPresident, CEOOption exercise
50.0K
$1.87$93.5K
2026-03-23STEFANOVICH ROBERTChief Financial OfficerSell (open market)
1.1K
$8.18$8.9K
2026-03-23SHELTON JERRELLPresident, CEOSell (open market)
2.9K
$8.18$23.7K
2026-03-23SHELTON JERRELLPresident, CEOOption exercise
25.0K
$1.87$46.8K
2026-03-23Sawicki Mark WChief Scientific OfficerSell (open market)
1.3K
$8.18$11.0K
2026-03-16ZECCHINI EDWARD JSee RemarksSell (open market)
2.0K
$8.00$16.1K
2026-03-16SHELTON JERRELLPresident, CEOSell (open market)
7.9K
$8.00$63.3K
2026-03-16Sawicki Mark WChief Scientific OfficerSell (open market)
3.2K
$8.00$25.9K
2026-03-16STEFANOVICH ROBERTChief Financial OfficerSell (open market)
2.7K
$8.00$21.9K
110 of 15
Page 1 / 2